Aerpio Pharmaceuticals, Inc.

ARPO · NASDAQ
Analyze with AI
12/31/2024
12/31/2022
12/31/2021
12/31/2020
Operating Activities
Net Income-$64-$37-$23-$22
Dep. & Amort.-$1$1$1$1
Deferred Tax$0$0$0$0
Stock-Based Comp.$11$3$3$3
Change in WC$0$0$0$0
Other Non-Cash-$6$0-$4-$1
Operating Cash Flow-$60-$32-$24-$18
Investing Activities
PP&E Inv.-$2-$2-$1-$1
Net Acquisitions$0$0$0$0
Inv. Purchases-$36$0$0$0
Inv. Sales/Matur.$63$0$0$0
Other Inv. Act.$0$0$0$0
Investing Cash Flow$25-$2-$1-$1
Financing Activities
Debt Repay.$0$0$0$0
Stock Issued$0$0$0$0
Stock Repurch.$0$0$0$0
Dividends Paid$0$0$0$0
Other Fin. Act.$0$44$26$23
Financing Cash Flow$0$44$26$23
Forex Effect$0$0$0$0
Net Chg. in Cash-$34$9$1$4
Supplemental Information
Beg. Cash$63$11$11$7
End Cash$29$21$11$11
Free Cash Flow-$61-$35-$25-$19
Aerpio Pharmaceuticals, Inc. (ARPO) Financial Statements & Key Stats | AlphaPilot